Prot# NN8022-1922: Effect of Liraglutide on Body Weight in Overweight or Obese Subjects with Type 2 Diabetes. A 56 Week Randomised, Double-Blind, Placebo-Controlled, Three Armed Parallel Group, Multi-Centre, Multinational Trial With a 12 Week Observation

Project: Research project

Project Details

StatusFinished
Effective start/end date6/23/116/23/14

Funding

  • Novo Nordisk Inc. (NN8022-1922)